Cargando…

Therapy of chronic hepatitis C in people who inject drugs: focus on adherence

BACKGROUND: Intravenous drug use (IVDU) represents the major factor of HCV transmission, but the treatment uptake among people who inject drugs (PWID) remains low owing to a false presumption of low efficacy. The aim of our study was to assess treatment efficacy in PWID and factors determining adher...

Descripción completa

Detalles Bibliográficos
Autores principales:	Frankova, Sona, Jandova, Zuzana, Jinochova, Gabriela, Kreidlova, Miluse, Merta, Dusan, Sperl, Jan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247095/ https://www.ncbi.nlm.nih.gov/pubmed/34193156 http://dx.doi.org/10.1186/s12954-021-00519-y

Ejemplares similares

Combination of sofosbuvir and daclatasvir in the treatment of genotype 3 chronic hepatitis C virus infection in patients on maintenance hemodialysis
por: Sperl, Jan, et al.
Publicado: (2017)

Predictors of Significant Liver Fibrosis in People with Chronic Hepatitis C Who Inject Drugs in the Czech Republic
por: Frankova, Sona, et al.
Publicado: (2023)

PNPLA3 rs738409 G allele carriers with genotype 1b HCV cirrhosis have lower viral load but develop liver failure at younger age
por: Senkerikova, Renata, et al.
Publicado: (2019)

USP18 downregulation in peripheral blood mononuclear cells predicts nonresponse to interferon-based triple therapy in patients with chronic hepatitis C, genotype 1: a pilot study
por: Frankova, Sona, et al.
Publicado: (2015)

Transient Elastography as the First-Line Assessment of Liver Fibrosis and Its Correlation with Serum Markers
por: Uzlova, Nikola, et al.
Publicado: (2023)

Alpha-1 Antitrypsin and Hepatocellular Carcinoma in Liver Cirrhosis: SERPINA1 MZ or MS Genotype Carriage Decreases the Risk
por: Rabekova, Zuzana, et al.
Publicado: (2021)

Factors associated with uptake, adherence, and efficacy of hepatitis C treatment in people who inject drugs: a literature review
por: Mravčík, Viktor, et al.
Publicado: (2013)

Incidence of hepatitis C among people who inject drugs in Ireland
por: Carew, Anne Marie, et al.
Publicado: (2017)

How close are we to hepatitis C virus elimination in Central Europe?
por: Flisiak, Robert, et al.
Publicado: (2020)

Hepatitis C Transmission and Treatment in Contact Networks of People Who Inject Drugs
por: Rolls, David A., et al.
Publicado: (2013)

Eradication of hepatitis C infection: The importance of targeting people who inject drugs
por: Hellard, Margaret, et al.
Publicado: (2014)

Urgent action to fight hepatitis C in people who inject drugs in Europe
por: Dillon, John F., et al.
Publicado: (2016)

Mitochondrial Genotoxicity of Hepatitis C Treatment among People Who Inject Drugs
por: Durand, Mélusine, et al.
Publicado: (2021)

Hepatitis C virus risk among young people who inject drugs
por: Mateu-Gelabert, Pedro, et al.
Publicado: (2022)

More intensive hepatitis C virus care models promote adherence among people who inject drugs with active drug use: The PREVAIL study
por: Heo, Moonseong, et al.
Publicado: (2022)

Liver stiffness measured by two-dimensional shear-wave elastography predicts hepatic vein pressure gradient at high values in liver transplant candidates with advanced liver cirrhosis
por: Frankova, Sona, et al.
Publicado: (2021)

HIV treatment, antiretroviral adherence and AIDS mortality in people who inject drugs: a scoping review
por: Uusküla, Anneli, et al.
Publicado: (2023)

Barriers to receiving hepatitis C treatment for people who inject drugs: Myths and evidence
por: Higgs, Peter, et al.
Publicado: (2011)

Hepatitis C serosorting among people who inject drugs in rural Puerto Rico
por: Duncan, Ian, et al.
Publicado: (2017)

Modeling Hepatitis C Elimination Among People Who Inject Drugs in New Hampshire
por: Blake, Andrew, et al.
Publicado: (2021)

Hepatitis C Virus Dynamic Transmission Models Among People Who Inject Drugs
por: Woyesa, Shiferaw Bekele, et al.
Publicado: (2023)

1050. Hepatitis C Infection amongst People who Inject Drugs (PWID): Injection Practices and Risk Factors
por: Sankar, Nityasri, et al.
Publicado: (2020)

Adherence to response-guided pegylated interferon and ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: the ACTIVATE study
por: Cunningham, Evan B., et al.
Publicado: (2017)

Outcomes from a large 10 year hepatitis C treatment programme in people who inject drugs: No effect of recent or former injecting drug use on treatment adherence or therapeutic response
por: Elsherif, Omar, et al.
Publicado: (2017)

Assisted injection among people who inject drugs in Thailand
por: Lee, William K, et al.
Publicado: (2013)

Hepatitis C Virus Phylogenetic Clustering Is Associated with the Social-Injecting Network in a Cohort of People Who Inject Drugs
por: Sacks-Davis, Rachel, et al.
Publicado: (2012)

Reduction in Depressive Symptoms in People who Inject Drugs who Are Cured of Hepatitis C Virus Infection: The HERO Study
por: Pericot-Valverde, Irene, et al.
Publicado: (2023)

Transmission Patterns of HIV and Hepatitis C Virus among Networks of People Who Inject Drugs
por: Pilon, Richard, et al.
Publicado: (2011)

HIV and hepatitis B and C co-infection among people who inject drugs in Zanzibar
por: Khatib, Ahmed, et al.
Publicado: (2017)

The hepatitis C cascade of care in people who inject drugs in Dar es Salaam, Tanzania
por: Mohamed, Zameer, et al.
Publicado: (2018)

Factors associated with phylogenetic clustering of hepatitis C among people who inject drugs in Baltimore
por: Falade-Nwulia, Oluwaseun, et al.
Publicado: (2020)

Are there missed opportunities for vaccinating against hepatitis B among people who inject drugs in the UK?
por: Njoroge, J., et al.
Publicado: (2019)

Intra-host evolutionary dynamics of the hepatitis C virus among people who inject drugs
por: Montoya, Vincent, et al.
Publicado: (2021)

Model of Care for Microelimination of Hepatitis C Virus Infection among People Who Inject Drugs
por: Foschi, Francesco Giuseppe, et al.
Publicado: (2021)

Values and preferences for hepatitis C self-testing among people who inject drugs in Kyrgyzstan
por: Martínez-Pérez, Guillermo Z., et al.
Publicado: (2021)

Prevalence of hepatitis B and C, HIV, and syphilis among people who inject drugs in Germany
por: Steffen, G, et al.
Publicado: (2022)

Time-to-hepatitis C treatment initiation among people who inject drugs in Melbourne, Australia
por: Aung, Phyo T. Z., et al.
Publicado: (2023)

Prevalence and Seroincidence of Hepatitis B and Hepatitis C Infection in High Risk People Who Inject Drugs in China and Thailand
por: Jackson, J. Brooks, et al.
Publicado: (2014)

HIV among people who inject drugs in Hungary
por: Ortutay, András, et al.
Publicado: (2017)

Estimating the number of people who inject drugs in Australia
por: Larney, Sarah, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_4ojpeitpd1rbtu7th1otdjh9ll